Worldwide Clinical Trials acquires Catalyst Clinical Research

Worldwide Clinical Trials agreed to acquire Catalyst Clinical Research. Reported deal value: Undisclosed. Status: Pending. Sector: Contract Research Organization (CRO). Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-28. Figures and status may change as filings and press coverage update.

Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research , a specialized oncology -focused contract research organization , in a move aimed at strengthening oncology expertise, expanding functional service provider offerings, and enhancing global trial delivery.1 The transaction brings together Worldwide late-phase and CNS development strengths with Catalyst early phase oncology capabilities , biometrics expertise, and flexible FSP model, positioning the combined organization to support a broader range of oncology programs across the developmen...